MedPath

Effects of a Test Food for Cognitive Functio

Not Applicable
Conditions
/A(healthy adults)
Registration Number
JPRN-UMIN000050978
Lead Sponsor
MORINAGA & CO., LTD.
Brief Summary

Published at Jpn. Pharmacol. Ther. vol.51, no.9, pp.1355-1363 (2023)

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
20
Inclusion Criteria

Not provided

Exclusion Criteria

1) Individuals using medical products. 2) Individuals with dementia. 3) Individuals who used a drug for treatment of disease in the past 1 month. 4) Individuals who have a history of serious hepatopathy, kidney damage, heart disease, hematological and blood disease. 5) Individuals who contract or have a history of serious gastrointestinal disease. 6) Individuals with serious anemia. 7) Individuals who contract or have a history of food allergy. (milk) 8) Females who are or are possibly pregnant, or are lactating. 9) Individuals who have an addiction to alcohol or a mental illness. 10) Individuals who are a smoker. 11) Individuals whose life style will change during the test period. 12) Individuals with probable seasonal allergy, such as pollinosis, during the test period.(Betulaceae: alder, oba alnus firma, shirakaba, Taxodiaceae: cryptomeria, hinoki cypress, Asteraceae: ragweed, Artemisia vulgaris indica, Gramineae:Dactylis glomerata, Phleum pratense) 13) Individuals who had a habit to ingest health-promoting foods, foods for specified health uses, health foods, or supplements in the past 3 months or will ingest those foods during the test period. 14) Individuals who had a habit to ingest foods claiming to improve cognitive function, foods for specified health uses, health foods, or supplements in the past 3 months or will ingest those foods during the test period. 15) Individuals who have a habit to use drug claiming to improve cognitive function in the past 3 months. 16) Individuals who conducted hormone replacement therapy in the past 6 months or have a history of conducting hormone replacement therapy. 17) Individuals who were hospitalized and received treatment in the past 6 months, or will be hospitalized during the test period. 18) Individuals who participated in other clinical studies in the past 1 months. 19) Individuals judged inappropriate for the study by the principal.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Cognitive function test by Cognitrax
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath